ConductScience.org, home

Paper36097193

Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype.

Kang S and 6 others. Oncogene, 2022. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype. Papers, record 36097193. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36097193

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype.
PubMed
Journal
Oncogene
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.99
iCite
Revised in PubMed
2022-12-22
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kang SSynathttps://orcid.org/0000-0001-6898-5289
2Wang LLixin
3Xu LLu
4Wang RRuiqi
5Kang QQingzheng
6Gao XXuefenghttps://orcid.org/0000-0002-1904-392X
7Yu LLihttps://orcid.org/0000-0001-6872-2665

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Leukemia, Myeloid, AcuteMajor topic
T-LymphocytesMajor topic
Animals
Cell Line, Tumor
Decitabine
Humans
Membrane Proteins
Mice
Phenotype
Receptors, Antigen, T-Cell
Receptors, CCR7
Tumor Necrosis Factor-alpha

Source PubMed

Download CSV of topics

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132249005Selection of initial therapy for newly-diagnosed adult acute myeloid leukemia: Limitations of predictive models.Blood Rev2020https://conductscience.org/library/papers/32249005PubMed
230626574Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors.Blood Adv2019https://conductscience.org/library/papers/30626574PubMed
326031916Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy.Blood2015https://conductscience.org/library/papers/26031916PubMed
423478054Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.J Clin Oncol2013https://conductscience.org/library/papers/23478054PubMed
530578254Mechanisms of immune escape after allogeneic hematopoietic cell transplantation.Blood2019https://conductscience.org/library/papers/30578254PubMed
629567707CAR T cell immunotherapy for human cancer.Science2018https://conductscience.org/library/papers/29567707PubMed
730622438T cell receptor-engineered T cells for leukemia immunotherapy.Cancer Cell Int2019https://conductscience.org/library/papers/30622438PubMed
828860210Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.Blood2017https://conductscience.org/library/papers/28860210PubMed
929972754Chimeric Antigen Receptor Therapy.N Engl J Med2018https://conductscience.org/library/papers/29972754PubMed
1029155426CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy.Nat Med2018https://conductscience.org/library/papers/29155426PubMed
1127111235CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.J Clin Invest2016https://conductscience.org/library/papers/27111235PubMed
1232435621CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions.Front Oncol2020https://conductscience.org/library/papers/32435621PubMed
1331235963T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant.Nat Med2019https://conductscience.org/library/papers/31235963PubMed
1427776339Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies.Oncotarget2016https://conductscience.org/library/papers/27776339PubMed
1521282551Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.J Clin Oncol2011https://conductscience.org/library/papers/21282551PubMed
1611351307Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues.Int J Cancer2001https://conductscience.org/library/papers/11351307PubMed
1725538264A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.Clin Cancer Res2015https://conductscience.org/library/papers/25538264PubMed
1830546433Treatment of metastatic non-small cell lung cancer with NY-ESO-1 specific TCR engineered-T cells in a phase I clinical trial: A case report.Oncol Lett2018https://conductscience.org/library/papers/30546433PubMed
1931289029Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma.Blood Adv2019https://conductscience.org/library/papers/31289029PubMed
2026193344NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.Nat Med2015https://conductscience.org/library/papers/26193344PubMed

See all 59 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42925407Decitabine and azacitidine exert multifaceted effects beyond DNA hypomethylation in myeloid neoplasms.Int J Hematol2026https://conductscience.org/library/papers/42925407PubMed
42480219Long-acting pegylated interferon gamma sensitizes AML cells to killing by donor T cells.Blood Adv2026https://conductscience.org/library/papers/42480219PubMed
42288680Targeting mitochondrial TRIP13-AIF interaction suppresses myeloid leukemia progression and overcomes drug resistance.Oncogene2026https://conductscience.org/library/papers/42288680PubMed
42194057Mechanism and Therapeutic Potential of Viral Mimicry in Cancer Immunotherapy.Biomolecules2026https://conductscience.org/library/papers/42194057PubMed
41986386Demethylation-primed tandem CD19/CD20 CAR T cells in relapsed/refractory B-cell lymphoma: a phase I/II trial.Nat Commun2026https://conductscience.org/library/papers/41986386PubMed
41769689Comparison of maintenance with decitabine or chemotherapy in a real-world cohort of patients with acute myeloid leukemia.Front Pharmacol2026https://conductscience.org/library/papers/41769689PubMed
41768369Immune Exhaustion in Chronic Infection and Cancer: Signaling Pathways and Therapeutic Interventions.MedComm (2020)2026https://conductscience.org/library/papers/41768369PubMed
40664662Combining decitabine with radiotherapy to enhance nasopharyngeal carcinoma radiosensitivity via the TFAP2C-OTUD1-SLC25A11 axis.Cell Death Dis2025https://conductscience.org/library/papers/40664662PubMed
40140361BH3 mimetics augment cytotoxic T cell killing of acute myeloid leukemia via mitochondrial apoptotic mechanism.Cell Death Discov2025https://conductscience.org/library/papers/40140361PubMed
39813621Current developments in T-cell receptor therapy for acute myeloid leukemia.Blood Adv2025https://conductscience.org/library/papers/39813621PubMed
38711501Higher TIGIT+ γδ TCM cells may predict poor prognosis in younger adult patients with non-acute promyelocytic AML.Front Immunol2024https://conductscience.org/library/papers/38711501PubMed
37228497Gene mutation landscape of a rare patient with acute megakaryoblastic leukemia after treatment of intracranial germ cell tumor.Front Oncol2023https://conductscience.org/library/papers/37228497PubMed
37153607The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy.Front Immunol2023https://conductscience.org/library/papers/37153607PubMed

Download CSV of cited by

Genes22

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
CCR71236PubTator's text mininghttps://conductscience.org/library/genes/1236NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTAG1A246100PubTator's text mininghttps://conductscience.org/library/genes/246100NCBI Gene
DNMT3A1788PubTator's text mininghttps://conductscience.org/library/genes/1788NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IL2RA3559PubTator's text mininghttps://conductscience.org/library/genes/3559NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
KLRC13821PubTator's text mininghttps://conductscience.org/library/genes/3821NCBI Gene
KLRK122914PubTator's text mininghttps://conductscience.org/library/genes/22914NCBI Gene
NCAM14684PubTator's text mininghttps://conductscience.org/library/genes/4684NCBI Gene
NR1I39970PubTator's text mininghttps://conductscience.org/library/genes/9970NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene
PTPRC5788PubTator's text mininghttps://conductscience.org/library/genes/5788NCBI Gene
SELL6402PubTator's text mininghttps://conductscience.org/library/genes/6402NCBI Gene

See all 22 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36097193

GET https://conductscience.org/api/papers/v1/36097193/references?page=2